LinkedIn Profile

Access Clovis Oncology historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
nasdaq:clvs 904367 Jun 4th, 2020 12:00AM Clovis Oncology 13K 511.00 Open Biotechnology Jun 4th, 2020 12:36PM Jun 4th, 2020 12:36PM Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial-stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our product development programs generally target specific subsets of cancer, and we aim to simultaneously develop, with partners, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use. Through these collaborations, Clovis has the flexibility to choose the most appropriate technology for each program, and the expertise to gain regulatory approvals and support global commercialization that will parallel Clovis’ regulatory and commercialization paths. We believe this approach to precision medicine—to deliver the right drug to the right patient at the right time—represents the future of cancer therapy. Clovis Oncology’s management team has extensive experience in the development of novel cancer therapies and a shared commitment to the company’s vision. Clovis Oncology is headquartered in Boulder, Colorado. Please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe. Open oncology drug development, companion diagnostics, biotechnology Open 5500 Flatiron Parkway Boulder CO US 80301 Health Care Pharmaceuticals & Biotechnology
nasdaq:clvs 904367 Jun 3rd, 2020 12:00AM Clovis Oncology 13K 511.00 Open Biotechnology Jun 2nd, 2020 10:15PM Jun 2nd, 2020 10:15PM Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial-stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our product development programs generally target specific subsets of cancer, and we aim to simultaneously develop, with partners, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use. Through these collaborations, Clovis has the flexibility to choose the most appropriate technology for each program, and the expertise to gain regulatory approvals and support global commercialization that will parallel Clovis’ regulatory and commercialization paths. We believe this approach to precision medicine—to deliver the right drug to the right patient at the right time—represents the future of cancer therapy. Clovis Oncology’s management team has extensive experience in the development of novel cancer therapies and a shared commitment to the company’s vision. Clovis Oncology is headquartered in Boulder, Colorado. Please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe. Open oncology drug development, companion diagnostics, biotechnology Open 5500 Flatiron Parkway Boulder CO US 80301 Health Care Pharmaceuticals & Biotechnology
nasdaq:clvs 904367 Jun 2nd, 2020 12:00AM Clovis Oncology 13K 511.00 Open Biotechnology Jun 2nd, 2020 11:38AM Jun 2nd, 2020 11:38AM Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial-stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our product development programs generally target specific subsets of cancer, and we aim to simultaneously develop, with partners, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use. Through these collaborations, Clovis has the flexibility to choose the most appropriate technology for each program, and the expertise to gain regulatory approvals and support global commercialization that will parallel Clovis’ regulatory and commercialization paths. We believe this approach to precision medicine—to deliver the right drug to the right patient at the right time—represents the future of cancer therapy. Clovis Oncology’s management team has extensive experience in the development of novel cancer therapies and a shared commitment to the company’s vision. Clovis Oncology is headquartered in Boulder, Colorado. Please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe. Open oncology drug development, companion diagnostics, biotechnology Open 5500 Flatiron Parkway Boulder CO US 80301 Health Care Pharmaceuticals & Biotechnology
nasdaq:clvs 904367 Jun 1st, 2020 12:00AM Clovis Oncology 13K 511.00 Open Biotechnology Jun 1st, 2020 11:16AM Jun 1st, 2020 11:16AM Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial-stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our product development programs generally target specific subsets of cancer, and we aim to simultaneously develop, with partners, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use. Through these collaborations, Clovis has the flexibility to choose the most appropriate technology for each program, and the expertise to gain regulatory approvals and support global commercialization that will parallel Clovis’ regulatory and commercialization paths. We believe this approach to precision medicine—to deliver the right drug to the right patient at the right time—represents the future of cancer therapy. Clovis Oncology’s management team has extensive experience in the development of novel cancer therapies and a shared commitment to the company’s vision. Clovis Oncology is headquartered in Boulder, Colorado. Please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe. Open oncology drug development, companion diagnostics, biotechnology Open 5500 Flatiron Parkway Boulder CO US 80301 Health Care Pharmaceuticals & Biotechnology
nasdaq:clvs 904367 May 31st, 2020 12:00AM Clovis Oncology 13K 508.00 Open Biotechnology May 30th, 2020 10:15PM May 30th, 2020 10:15PM Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial-stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our product development programs generally target specific subsets of cancer, and we aim to simultaneously develop, with partners, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use. Through these collaborations, Clovis has the flexibility to choose the most appropriate technology for each program, and the expertise to gain regulatory approvals and support global commercialization that will parallel Clovis’ regulatory and commercialization paths. We believe this approach to precision medicine—to deliver the right drug to the right patient at the right time—represents the future of cancer therapy. Clovis Oncology’s management team has extensive experience in the development of novel cancer therapies and a shared commitment to the company’s vision. Clovis Oncology is headquartered in Boulder, Colorado. Please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe. Open oncology drug development, companion diagnostics, biotechnology Open 5500 Flatiron Parkway Boulder CO US 80301 Health Care Pharmaceuticals & Biotechnology
nasdaq:clvs 904367 May 30th, 2020 12:00AM Clovis Oncology 13K 508.00 Open Biotechnology May 30th, 2020 12:59PM May 30th, 2020 12:59PM Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial-stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our product development programs generally target specific subsets of cancer, and we aim to simultaneously develop, with partners, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use. Through these collaborations, Clovis has the flexibility to choose the most appropriate technology for each program, and the expertise to gain regulatory approvals and support global commercialization that will parallel Clovis’ regulatory and commercialization paths. We believe this approach to precision medicine—to deliver the right drug to the right patient at the right time—represents the future of cancer therapy. Clovis Oncology’s management team has extensive experience in the development of novel cancer therapies and a shared commitment to the company’s vision. Clovis Oncology is headquartered in Boulder, Colorado. Please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe. Open oncology drug development, companion diagnostics, biotechnology Open 5500 Flatiron Parkway Boulder CO US 80301 Health Care Pharmaceuticals & Biotechnology
nasdaq:clvs 904367 May 29th, 2020 12:00AM Clovis Oncology 13K 507.00 Open Biotechnology May 28th, 2020 10:15PM May 28th, 2020 10:15PM Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial-stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our product development programs generally target specific subsets of cancer, and we aim to simultaneously develop, with partners, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use. Through these collaborations, Clovis has the flexibility to choose the most appropriate technology for each program, and the expertise to gain regulatory approvals and support global commercialization that will parallel Clovis’ regulatory and commercialization paths. We believe this approach to precision medicine—to deliver the right drug to the right patient at the right time—represents the future of cancer therapy. Clovis Oncology’s management team has extensive experience in the development of novel cancer therapies and a shared commitment to the company’s vision. Clovis Oncology is headquartered in Boulder, Colorado. Please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe. Open oncology drug development, companion diagnostics, biotechnology Open 5500 Flatiron Parkway Boulder CO US 80301 Health Care Pharmaceuticals & Biotechnology
nasdaq:clvs 904367 May 28th, 2020 12:00AM Clovis Oncology 13K 507.00 Open Biotechnology May 28th, 2020 11:04AM May 28th, 2020 11:04AM Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial-stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our product development programs generally target specific subsets of cancer, and we aim to simultaneously develop, with partners, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use. Through these collaborations, Clovis has the flexibility to choose the most appropriate technology for each program, and the expertise to gain regulatory approvals and support global commercialization that will parallel Clovis’ regulatory and commercialization paths. We believe this approach to precision medicine—to deliver the right drug to the right patient at the right time—represents the future of cancer therapy. Clovis Oncology’s management team has extensive experience in the development of novel cancer therapies and a shared commitment to the company’s vision. Clovis Oncology is headquartered in Boulder, Colorado. Please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe. Open oncology drug development, companion diagnostics, biotechnology Open 5500 Flatiron Parkway Boulder CO US 80301 Health Care Pharmaceuticals & Biotechnology
nasdaq:clvs 904367 May 27th, 2020 12:00AM Clovis Oncology 13K 507.00 Open Biotechnology May 26th, 2020 10:15PM May 26th, 2020 10:15PM Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial-stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our product development programs generally target specific subsets of cancer, and we aim to simultaneously develop, with partners, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use. Through these collaborations, Clovis has the flexibility to choose the most appropriate technology for each program, and the expertise to gain regulatory approvals and support global commercialization that will parallel Clovis’ regulatory and commercialization paths. We believe this approach to precision medicine—to deliver the right drug to the right patient at the right time—represents the future of cancer therapy. Clovis Oncology’s management team has extensive experience in the development of novel cancer therapies and a shared commitment to the company’s vision. Clovis Oncology is headquartered in Boulder, Colorado. Please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe. Open oncology drug development, companion diagnostics, biotechnology Open 5500 Flatiron Parkway Boulder CO US 80301 Health Care Pharmaceuticals & Biotechnology
nasdaq:clvs 904367 May 26th, 2020 12:00AM Clovis Oncology 13K 508.00 Open Biotechnology May 26th, 2020 08:39AM May 26th, 2020 08:39AM Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial-stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Our product development programs generally target specific subsets of cancer, and we aim to simultaneously develop, with partners, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use. Through these collaborations, Clovis has the flexibility to choose the most appropriate technology for each program, and the expertise to gain regulatory approvals and support global commercialization that will parallel Clovis’ regulatory and commercialization paths. We believe this approach to precision medicine—to deliver the right drug to the right patient at the right time—represents the future of cancer therapy. Clovis Oncology’s management team has extensive experience in the development of novel cancer therapies and a shared commitment to the company’s vision. Clovis Oncology is headquartered in Boulder, Colorado. Please visit www.clovisoncology.com for more information, including additional office locations in the U.S. and Europe. Open oncology drug development, companion diagnostics, biotechnology Open 5500 Flatiron Parkway Boulder CO US 80301 Health Care Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.